Stock listing
LS Exchange:A41PJJ Xbrane Biopharma AB Aktie
German listing (LS Exchange) of Xbrane Biopharma AB · home listing Stockholm:XBRANE
Follow Xbrane Biopharma AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:XBRANE
13.00 SEK -1.15 (-8.1%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:XBRANE
- Day range
- 12.25 – 14.15 SEKNov 2, 2026
- Volume
- 260,478 sharesNov 2, 2026
- Market cap
- 267.9M SEKAt the close on Nov 2, 2026 · price × 20.61M shares outstanding
- 52-week range
- 5.42 – 20.00 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- 1.22M SEKMedian day 28,406 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:XBRANE · Home | 13.00 SEK | -1.15 (-8.1%) | 260,478 | 14.15 | 14.15 | 12.25 | 14.15 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:XBRANE · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 13.00 | -1.15 | -8.1% | 14.15 | 14.15 | 12.25 | 260,478 | |
| 14.15 | +1.15 | +8.8% | 13.80 | 15.50 | 13.70 | 483,796 | |
| 13.00 | -2.85 | -18.0% | 16.10 | 16.10 | 12.80 | 621,707 | |
| 15.85 | -1.55 | -8.9% | 17.85 | 17.85 | 15.40 | 510,491 | |
| 17.40 | +5.00 | +40.3% | 12.40 | 20.00 | 11.70 | 1,491,674 | |
| 12.40 | +0.40 | +3.3% | 11.95 | 12.95 | 11.55 | 65,413 | |
| 12.00 | -0.65 | -5.1% | 12.65 | 13.75 | 11.60 | 70,080 | |
| 12.65 | -0.85 | -6.3% | 13.45 | 13.75 | 12.65 | 52,650 | |
| 13.50 | +0.50 | +3.8% | 13.25 | 13.50 | 12.80 | 58,756 | |
| 13.00 | +0.75 | +6.1% | 12.25 | 13.55 | 12.00 | 52,343 | |
| 12.25 | +0.85 | +7.5% | 11.15 | 12.40 | 11.15 | 31,526 | |
| 11.40 | +0.20 | +1.8% | 11.10 | 11.55 | 11.00 | 29,098 | |
| 11.20 | -0.45 | -3.9% | 11.65 | 11.65 | 11.05 | 45,267 | |
| 11.65 | -0.70 | -5.7% | 12.40 | 12.40 | 11.45 | 73,561 | |
| 12.35 | -0.20 | -1.6% | 12.60 | 13.35 | 12.30 | 98,078 | |
| 12.55 | -1.40 | -10.0% | 14.00 | 14.00 | 12.05 | 106,050 | |
| 13.95 | +0.60 | +4.5% | 13.45 | 13.95 | 13.05 | 43,575 | |
| 13.35 | -0.15 | -1.1% | 13.40 | 13.50 | 12.50 | 30,156 | |
| 13.50 | -0.70 | -4.9% | 14.20 | 14.20 | 12.80 | 133,180 | |
| 14.20 | +1.70 | +13.6% | 12.45 | 14.25 | 12.45 | 234,066 | |
| 12.50 | +2.10 | +20.2% | 10.40 | 12.50 | 10.40 | 204,685 | |
| 10.40 | -0.15 | -1.4% | 10.50 | 10.85 | 10.30 | 18,246 | |
| 10.55 | -0.45 | -4.1% | 11.00 | 11.00 | 10.50 | 17,765 | |
| 11.00 | -0.10 | -0.9% | 11.00 | 11.10 | 10.75 | 14,364 | |
| 11.10 | +0.65 | +6.2% | 10.45 | 11.10 | 10.45 | 21,362 | |
| 10.45 | -0.15 | -1.4% | 10.75 | 11.00 | 10.35 | 61,964 | |
| 10.60 | +0.20 | +1.9% | 10.40 | 10.85 | 10.40 | 27,216 | |
| 10.40 | -0.20 | -1.9% | 10.60 | 10.60 | 10.25 | 14,635 | |
| 10.60 | +0.30 | +2.9% | 10.35 | 10.75 | 10.35 | 9,654 | |
| 10.30 | -0.35 | -3.3% | 10.55 | 10.65 | 10.20 | 11,387 | |
| 10.65 | +0.55 | +5.4% | 10.10 | 10.80 | 10.10 | 10,300 | |
| 10.10 | -0.10 | -1.0% | 10.20 | 10.35 | 10.10 | 6,365 | |
| 10.20 | -0.15 | -1.4% | 10.00 | 10.55 | 10.00 | 13,605 | |
| 10.35 | +0.05 | +0.5% | 10.30 | 10.35 | 9.92 | 21,916 | |
| 10.30 | 0.00 | 0.0% | 10.25 | 10.30 | 9.90 | 33,400 | |
| 10.30 | +0.20 | +2.0% | 10.20 | 10.35 | 9.90 | 17,203 | |
| 10.10 | -0.35 | -3.3% | 10.45 | 10.70 | 10.10 | 28,927 | |
| 10.45 | -0.25 | -2.3% | 10.60 | 10.80 | 10.40 | 17,242 | |
| 10.70 | -0.10 | -0.9% | 10.80 | 10.90 | 10.55 | 38,854 | |
| 10.80 | +0.50 | +4.9% | 10.45 | 10.90 | 10.40 | 27,885 | |
| 10.30 | +0.54 | +5.5% | 9.78 | 10.90 | 9.78 | 101,500 | |
| 9.76 | -0.24 | -2.4% | 9.90 | 10.30 | 9.76 | 20,232 | |
| 10.00 | 0.00 | 0.0% | 10.00 | 10.40 | 9.84 | 13,730 | |
| 10.00 | +0.42 | +4.4% | 9.58 | 10.00 | 9.42 | 19,877 | |
| 9.58 | +0.08 | +0.8% | 9.58 | 9.58 | 9.42 | 14,655 | |
| 9.50 | 0.00 | 0.0% | 9.40 | 9.58 | 9.04 | 22,309 | |
| 9.50 | +0.22 | +2.4% | 9.50 | 9.58 | 9.20 | 19,238 | |
| 9.28 | +0.10 | +1.1% | 9.20 | 9.50 | 9.14 | 8,689 | |
| 9.18 | -0.18 | -1.9% | 9.38 | 9.70 | 9.10 | 29,569 | |
| 9.36 | -0.14 | -1.5% | 9.50 | 9.70 | 9.28 | 34,437 | |
| 9.50 | 0.00 | 0.0% | 9.48 | 9.50 | 9.20 | 21,167 | |
| 9.50 | -0.06 | -0.6% | 9.58 | 9.60 | 9.18 | 40,545 | |
| 9.56 | -0.04 | -0.4% | 9.52 | 10.00 | 9.38 | 31,380 | |
| 9.60 | -0.06 | -0.6% | 9.44 | 9.86 | 9.44 | 44,764 | |
| 9.66 | -0.32 | -3.2% | 9.86 | 10.30 | 9.40 | 24,213 | |
| 9.98 | +0.24 | +2.5% | 9.74 | 10.00 | 9.44 | 59,730 | |
| 9.74 | +0.18 | +1.9% | 9.60 | 9.80 | 9.42 | 19,892 | |
| 9.56 | -0.16 | -1.6% | 9.72 | 9.76 | 9.44 | 25,733 | |
| 9.72 | +0.14 | +1.5% | 9.58 | 9.84 | 9.56 | 21,347 | |
| 9.58 | -0.57 | -5.6% | 10.15 | 10.15 | 9.50 | 39,876 | |
| 10.15 | +0.15 | +1.5% | 10.05 | 10.15 | 9.96 | 10,671 | |
| 10.00 | -0.10 | -1.0% | 9.98 | 10.10 | 9.86 | 20,761 | |
| 10.10 | 0.00 | 0.0% | 9.96 | 10.20 | 9.96 | 2,686 | |
| 10.10 | -0.05 | -0.5% | 10.00 | 10.20 | 9.92 | 13,829 | |
| 10.15 | -0.10 | -1.0% | 10.25 | 10.25 | 9.86 | 12,395 | |
| 10.25 | +0.10 | +1.0% | 9.98 | 10.30 | 9.94 | 5,118 |
- Ticker
- LS Exchange:A41PJJ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Jul 17, 2026
Xbrane Biopharma releases Interim Report for January-June 2026
Latest earnings call · Jul 17, 2026
Xbrane Biopharma (Stockholm:XBRANE) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 30, 2026
Q3 2026 Earnings Presentation
Earnings · 23 slides
Calls
Replays
Xbrane Biopharma (Stockholm:XBRANE) Q2 2026 Earnings Call
Fri, Jul 17, 2026 · 3:00 AM ET
Watch TranscriptXbrane Biopharma (Stockholm:XBRANE) Q1 2026 Earnings Call
Tue, May 05, 2026 · 3:00 AM ET
Watch TranscriptXbrane Biopharma (Stockholm:XBRANE) Q4 2025 Earnings Call
Fri, Feb 20, 2026 · 7:00 AM ET
Watch Transcript
Latest news
Xbrane Biopharma releases Interim Report for January-June 2026
Jul 17, 2026
Closed 10.60 (-0.9%) on Jul 17, 2026
Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane – Xbrane´s Biosimilar Candidate to Darzalex® (Daratumumab)
Jun 11, 2026
Closed 10.70 (0.0%) on Jun 12, 2026
Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) receives FDA BsUFA date of October 29, 2026 for its investigational biosimilar candidate to LUCENTIS® (ranibizumab)
Jun 3, 2026
Closed 10.60 (+7.1%) on Jun 4, 2026
Xbrane and its partner Intas agree on revised financing arrangement for Xbrane’s Xdivane development activities
May 5, 2026
Closed 9.72 (-1.6%) on May 5, 2026
XBRANE submits ranibizumab biosimilar candidate to FDA
Apr 30, 2026
Closed 11.00 (+10.0%) on Apr 30, 2026
Xbrane provides an update on the timeline for resubmission of the market authorization application in the United States
Mar 31, 2026
Closed 6.68 (+5.2%) on Apr 1, 2026
Xbrane has released the company's 2025 Annual and Sustainability Report. The report summarizes business, financial performance and work on sustainability.
Mar 31, 2026
Closed 6.35 (+5.5%) on Mar 31, 2026
Xbrane Biopharma releases Year-end Report 2025
Feb 20, 2026
Closed 8.70 (-13.0%) on Feb 20, 2026
Xbrane Biopharma resolves to issue 420,517 warrants to Fenja Capital II A/S under the conditional financing solution
Nov 24, 2025
Closed 9.81 (+12.1%) on Nov 25, 2025
XBRANE updates on timing for resubmission of the BLA for its ranibizumab biosimilar candidate to FDA
Nov 19, 2025
Closed 9.49 (-4.7%) on Nov 19, 2025
Decks
Q3 2026 Earnings Presentation
Earnings · 23 slides · Oct 30, 2026
Q2 2026 Earnings Presentation
Earnings · 18 slides · Jul 17, 2026
Q1 2026 Earnings Presentation
Earnings · 19 slides · May 5, 2026
Q4 2025 Earnings Presentation
Earnings · 19 slides · Feb 20, 2026
Xbrane Biopharma AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 12 in all · newest Jul 17, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Jul 17, 2026
- Decks
- 17 decks · latest Oct 30, 2026
Where Xbrane Biopharma AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:XBRANE · Home listing | Stockholm | Sweden | SEK |
| gettex:7XB0 | gettex | Germany | EUR |
| LS Exchange:A41PJJ · This page | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41PJJ | Lang & Schwarz | Germany | EUR |
| Aquis:XBRANS | Aquis | United Kingdom | SEK |
| Aquis:XBRANS | Aquis | United Kingdom | SEK |
| Frankfurt:7XB0 | Frankfurt | Germany | EUR |
| Munich:7XB0 | Munich | Germany | EUR |
| Stuttgart:7XB0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Xbrane Biopharma AB.